Study: Long-Term Use of Aspirin Doesn’t Lower Risk of Stroke in Some Patients with Atrial Fibrillation
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who are considered to be at low risk for stroke may not be effective as...
5-May-2017 4:45 AM EDT Add to Favorites
A new study has found that dementia rates increase when anticoagulation treatment is delayed for patients with atrial fibrillation, the most common heart arrhythmia in the world that affects more than 2.7 million American adults.
4-May-2017 10:00 AM EDT Add to Favorites
Researchers have identified a microRNA biomarker that demonstrates a strong association with the incidence of atrial fibrillation, the most common abnormal heart rhythm.
8-May-2017 6:35 AM EDT Add to Favorites
Combining Risk Scores Improves Identification of Atrial Fibrillation Patients Who Face Increased Risk of Dementia
Combining the Intermountain Mortality Risk Score (IMRS), developed by clinicians at Intermountain Healthcare, with the traditional CHA2DS2-VASc risk score, was more accurate in identifying at-risk patients than using the traditional score alone.
8-May-2017 8:55 AM EDT Add to Favorites
Combining Risk Scores Improves Decision-Making Process for Atrial Fibrillation Patients and Physicians
By combining a patient’s traditional risk score with the Intermountain Mortality Risk Score (IMRS), physicians and patients are better equipped to evaluate a patient’s individual risk of stroke, bleeding, and mortality with atrial fibrillation,...
11-May-2017 2:05 AM EDT Add to Favorites
A novel treatment offers kidney failure and kidney transplant patients with a rare disorder new hope. The treatment allows targeted elimination of plasma cell clones producing abnormal proteins that deposits in the kidneys and leads to kidney...
3-May-2017 8:05 AM EDT Add to Favorites
New Anti-Rejection Drug Reduces Weight Gain and Enhances Outcomes for Liver Transplant Recipients, New Study Finds
Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight gain, which is common after surgery and can lead to serious problems for transplant patients.
2-May-2017 7:00 PM EDT Add to Favorites
Hearst Health, a division of Hearst, and the Jefferson College of Population Health of Thomas Jefferson University, have announced that Utah-based Intermountain Healthcare is the winner of the 2017 Hearst Health Prize.
4-Apr-2017 6:00 AM EDT Add to Favorites
28-Mar-2014 9:00 AM EDT